Quick summary: Semaglutide is an FDA-approved GLP-1 receptor agonist that helps adults with obesity or weight-related conditions lose a meaningful amount of weight by reducing appetite and slowing gastric emptying. In clinical trials, participants typically lost 10–15% of body weight over one year. It is a prescription medication administered by injection once weekly and is not appropriate for everyone. A medical evaluation is required before starting treatment. Individual results vary.
Medically reviewed by the clinical team at OC Weight Loss & Med Spa. Last updated: June 12, 2026.
What Is Semaglutide?
Semaglutide belongs to a class of medications called GLP-1 receptor agonists. GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in the gut after eating. It signals the brain that you are full, slows the rate at which the stomach empties, and helps regulate blood sugar.
Semaglutide mimics this hormone, but at a higher, sustained concentration than the body produces on its own. The result is reduced appetite, fewer cravings, and a feeling of fullness that persists longer after meals. These physiological effects — not willpower or stimulants — drive the weight loss observed in clinical studies.
The injectable form is available under two brand names: Ozempic (approved for type 2 diabetes management) and Wegovy (approved specifically for chronic weight management in adults with obesity or overweight plus at least one weight-related condition). An oral daily formulation (Rybelsus) is also FDA-approved for type 2 diabetes. Your provider will determine which form and dosing schedule is appropriate for your situation.
What the Clinical Evidence Shows
Semaglutide for weight management is one of the more thoroughly studied medications in this category. In the STEP clinical trial program, adults with obesity who used semaglutide 2.4 mg weekly alongside lifestyle modification lost an average of approximately 15% of their body weight over 68 weeks — significantly more than participants on placebo. Many also saw improvements in blood pressure, blood sugar, and waist circumference.
These are population averages. Individual response varies based on starting weight, metabolic health, dietary habits, activity level, and adherence to the full treatment plan. Some patients lose more; others less. Weight loss medications work best as one component of a broader program that includes nutritional guidance and regular follow-up with a medical provider.
Who Is a Candidate?
FDA labeling for Wegovy indicates use in adults who meet one of these criteria:
- BMI of 30 or higher (obesity)
- BMI of 27 or higher (overweight) with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
Semaglutide is a prescription medication. Candidacy is determined through a medical consultation that reviews your health history, current medications, and treatment goals. It is not a first-line option for people who are slightly above their preferred weight, and it is not a cosmetic treatment.
Safety, Side Effects, and Who Should Not Use Semaglutide
Semaglutide is generally well tolerated, but side effects are common, especially early in treatment as the dose is gradually increased.
Common side effects include nausea, vomiting, diarrhea, constipation, and stomach pain. These tend to be most noticeable in the first several weeks and often improve as the body adjusts. Starting at a low dose and titrating slowly helps reduce their severity.
Less common but serious risks include pancreatitis (inflammation of the pancreas) and gallbladder problems. Patients should tell their provider immediately if they experience severe or persistent abdominal pain.
Boxed warning — thyroid C-cell tumors: Semaglutide carries an FDA boxed warning (the most serious label warning) because it caused thyroid C-cell tumors in rodent studies. It is not known whether this risk applies to humans. Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients should report any neck lump, hoarseness, difficulty swallowing, or shortness of breath to their provider.
Who should not use semaglutide:
- Personal or family history of MTC or MEN 2
- Known hypersensitivity to semaglutide or any ingredient in the formulation
- Pregnancy or planned pregnancy — discontinue at least two months before attempting conception
- Patients with a history of pancreatitis (use with caution; discuss thoroughly with your provider)
This list is not exhaustive. Your provider will review your complete health history before prescribing.
What to Expect During Treatment
Treatment typically begins at a low weekly injection dose, which is increased gradually over several months to minimize side effects. Most patients reach their maintenance dose within 16–20 weeks.
Weight loss tends to be gradual. Most patients notice changes within the first month, with more meaningful results visible at three to six months. The medication works best alongside attention to food quality, portion awareness, and physical activity — not as a replacement for these habits.
Clinical studies show that patients who discontinue semaglutide without maintaining lifestyle changes typically regain a significant portion of the weight they lost. This is not a personal failure — it reflects the chronic, physiological nature of obesity. Many patients choose to continue on a maintenance dose long-term under medical supervision.
Frequently Asked Questions
How is semaglutide different from older weight loss medications?
Earlier weight loss medications worked primarily through stimulant mechanisms (suppressing appetite via the central nervous system) or fat-absorption blockade. GLP-1 receptor agonists like semaglutide work through a different pathway — mimicking a gut hormone to create a physiological sense of fullness and improving metabolic signaling. The clinical weight-loss outcomes with semaglutide are generally larger than those seen with most older medications, based on available trial data.
Do I need to follow a diet while taking semaglutide?
The medication reduces appetite and makes it easier to eat less, but food quality still matters. Patients who pay attention to protein intake, whole foods, and adequate hydration tend to see better results and maintain more muscle mass during weight loss. Your provider or a registered dietitian can help you build a realistic eating approach.
What happens if I stop taking semaglutide?
The appetite-regulating effects of semaglutide diminish after stopping. Clinical follow-up studies have shown that patients tend to regain weight after discontinuation, particularly if lifestyle habits have not been reinforced. Whether to continue, pause, or taper treatment is a decision made with your provider based on your health status and goals.
Is the weekly injection painful?
The injection uses a very fine needle and is administered subcutaneously (under the skin, typically in the abdomen, thigh, or upper arm). Most patients find the injections manageable. Your provider will show you the correct technique at your first visit.
Does insurance cover semaglutide for weight loss?
Coverage varies widely by insurance plan and employer. Wegovy is covered by some commercial plans and Medicare Part D for eligible patients, but prior authorization requirements are common. Our team can help review your options. Financing through Cherry or CareCredit may also be available for those who pay out of pocket.
Semaglutide Treatment at OC Weight Loss & Med Spa
At OC Weight Loss & Med Spa in Mission Viejo, CA, semaglutide is prescribed and monitored by Lindsay Short, NP, under the physician supervision of Dr. Nezar Dahdal, MD. Every patient begins with a thorough medical evaluation to confirm candidacy and rule out contraindications. We start at conservative doses, titrate based on your response, and provide ongoing follow-up throughout your program.
Weight loss is a medical matter, not a trend. If you have questions about whether semaglutide is appropriate for your situation, we encourage you to schedule a free consultation. There is no obligation, and you will leave with a clear picture of your options.
Book a free consultation
Book a Free Consultation